SCHEMBL21882218

SCHEMBL21882218

C=C(C)NC1=CC(=O)c2cccnc2C1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 7/20 0.77
TDP2 O95551 4/20 0.54
CDC25B P30305 4/20 0.54
NSD2 O96028 3/20 0.54
G6PD P11413 2/20 0.54
DUSP3 P51452 1/20 0.54
HKDC1 Q2TB90 1/20 0.54
TGM2 P21980 1/20 0.51
PADI1 Q9ULC6 1/20 0.51
PADI3 Q9ULW8 1/20 0.51
PADI4 Q9UM07 1/20 0.51
PADI2 Q9Y2J8 1/20 0.51
NQO1 P15559 2/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
THRB P10828 1/20 0.46
BLM P54132 1/20 0.46
GUCY1B2 O75343 1/20 0.45
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2599397 0.87 S100A4 (1.00) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL7648238 0.80 S100A4 (0.68) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL8651660 0.74 MAPT (0.78) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL12760676 0.72 PADI1 (0.64) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL15552423 0.72 PADI1 (0.64) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL15698467 0.71 S100A4 (0.63) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL7648160 0.71 TDP2 (0.74) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL7651620 0.71 PADI1 (0.58) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL13940474 0.71 S100A4 (0.58) S100A4TDP2CDC25BNSD2G6PD
SCHEMBL7678312 0.70 TDP2 (0.60) S100A4TDP2CDC25BNSD2G6PD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020055192-A2 PREPARATION METHOD FOR QUINOLINE-5, 8-DIONE DERIVATIVE WHICH IS TGASE 2 INHIBITOR 재단법인 대구경북첨단의료산업진흥재단 2020-03-19 WO disclosed